SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001860782-24-000052
Filing Date
2024-04-01
Accepted
2024-04-01 17:20:51
Documents
16
Period of Report
2024-03-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A tvst-20240329.htm   iXBRL 8-K/A 33109
2 EX-10.1 a-conformedfor8xkexxnickle.htm EX-10.1 55668
3 EX-99.1 exhibit991unauditedproform.htm EX-99.1 134396
4 EX-99.2 pressrelease-firefoxclosing.htm EX-99.2 13387
  Complete submission text file 0001860782-24-000052.txt   393561

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20240329.xsd EX-101.SCH 2010
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20240329_lab.xml EX-101.LAB 22530
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20240329_pre.xml EX-101.PRE 13144
20 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20240329_htm.xml XML 2810
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40791 | Film No.: 24811022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)